SCHEMBL17548426

SCHEMBL17548426

Cc1cccc(CSc2nc(-c3cccs3)c(Br)c(=O)[nH]2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACMSD Q8TDX5 9/20 0.74
MAPT P10636 3/20 0.52
HPGD P15428 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ALDH1A1 P00352 2/20 0.52
TP53 P04637 1/20 0.52
CYP2C19 P33261 1/20 0.51
L3MBTL1 Q9Y468 3/20 0.50
USP2 O75604 2/20 0.50
PRNP P04156 1/20 0.50
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
BLM P54132 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
SAE1 Q9UBE0 1/20 0.50
UBA2 Q9UBT2 1/20 0.50
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17553535 0.86 ACMSD (0.71) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL17548490 0.85 ACMSD (1.00) ACMSDMEN1KMT2ACYP2C19L3MBTL1
SCHEMBL17548422 0.83 ACMSD (0.73) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL17548431 0.80 ACMSD (0.72) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL23892639 0.76 ACMSD (0.84) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL17548438 0.75 ACMSD (0.78) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL23849818 0.73 ACMSD (0.76) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL31053424 0.73 ACMSD (0.76) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL31053406 0.73 ACMSD (0.78) ACMSDMAPTHPGDMEN1KMT2A
SCHEMBL23850223 0.73 ACMSD (0.78) ACMSDMAPTHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186242-B1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-10-06 EP disclosed
US-20170362185-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2017-12-21 US disclosed
US-9708272-B2 Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylase TES PHARMA S.R.L. (IT) 2017-07-18 US disclosed
US-20160060226-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2016-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160060226-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MAPT 1263/4885HPGD 59/4885
US-20170362185-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885MAPT 1263/4885HPGD 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.